Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $40.00

Key Points

• Mizuho has raised its price target for Omega Healthcare Investors (NYSE:OHI) from $37.00 to $40.00, while maintaining a "neutral" rating, suggesting a potential downside of 6.60% from the current stock price.
• Other analysts have also increased their price targets, with Truist Financial setting theirs at $44.00, indicating a consensus price target of $43.75 across multiple analysts for the stock.
• Omega Healthcare Investors reported strong earnings, beating analysts' expectations by posting $0.77 EPS for the last quarter, a significant increase from the previous year, alongside revenue growth of 11.8% year-over-year.

Omega Healthcare Investors (NYSE:OHI - Free Report) had its price target increased by Mizuho from $37.00 to $40.00 in a report issued on Thursday,Benzinga reports. The firm currently has a neutral rating on the real estate investment trust's stock.

Several other equities research analysts have also weighed in on the company. Scotiabank raised their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 28th. Royal Bank Of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Wells Fargo & Company raised their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Truist Financial boosted their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.75.

Omega Healthcare Investors Stock Down 0.8%

OHI traded down $0.36 on Thursday, reaching $42.33. The company's stock had a trading volume of 350,710 shares, compared to its average volume of 2,332,489. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. The business's 50 day moving average is $40.38 and its 200 day moving average is $38.29. Omega Healthcare Investors has a 1 year low of $35.04 and a 1 year high of $44.42. The stock has a market cap of $12.49 billion, a price-to-earnings ratio of 26.13, a price-to-earnings-growth ratio of 2.22 and a beta of 0.71.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same quarter last year, the business posted $0.71 EPS. The business's revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, research analysts forecast that Omega Healthcare Investors will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were issued a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.3%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 165.43%.

Insider Transactions at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.50% of the company's stock.

Institutional Investors Weigh In On Omega Healthcare Investors

Hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd bought a new stake in shares of Omega Healthcare Investors during the second quarter worth $26,000. NBC Securities Inc. acquired a new position in Omega Healthcare Investors in the first quarter valued at $29,000. Smartleaf Asset Management LLC raised its holdings in shares of Omega Healthcare Investors by 40.9% during the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock valued at $34,000 after purchasing an additional 268 shares during the period. CENTRAL TRUST Co raised its holdings in shares of Omega Healthcare Investors by 1,654.4% during the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 943 shares during the period. Finally, Bayforest Capital Ltd increased its position in shares of Omega Healthcare Investors by 395.2% during the second quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust's stock worth $41,000 after acquiring an additional 901 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.